Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEC-162 Phase 3 Study in Primary Insomnia
NCT00548340Phase 3Completed
- Sponsor
- Vanda Pharmaceuticals Inc.
- Start
- Nov 2007
- Primary completion
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tasimelteon in Insomnia, sponsored by Vanda Pharmaceuticals Inc.. Started Nov 2007; status: completed.
02
Drugs
tasimelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00548340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00548340.